Journal of Immunology Research

Epigenetics: a Growing Regulator in Immunology

Publishing date
01 Aug 2021
Submission deadline
19 Mar 2021

Lead Editor

1Wake Forest School of Medicine, Winston-Salem, USA

2Cleveland Clinic Lerner College of Medicine, Cleveland, USA

3Zhejiang University, Hangzhou, China

This issue is now closed for submissions.
More articles will be published in the near future.

Epigenetics: a Growing Regulator in Immunology

This issue is now closed for submissions.
More articles will be published in the near future.


In the late 19th century, Mendel’s pea plant experiments demonstrated that invisible genes control visible traits, and that the traits could be inherited to offspring through the transmission of a gene from a parent. A mutation may change the corresponding trait. Epigenetics was coined by Waddington in 1942, and finally, a consensus definition was made as "stably heritable phenotype resulting from changes in a chromosome without alterations in the DNA sequence".

Epigenetic mechanisms turn on/off a DNA/RNA or protein expression level, or up-/down-regulate a molecular activity, based on the “exposure” to all kinds of environmental stimulations and developmental changes. Currently, epigenetics, especially DNA methylation and protein acetylation, has been investigated widely and is becoming one of the hot research fields. For example, DNA methyltransferase 1 and 3b can polarize macrophages by methylating PPARg1 promoter, contributing to inflammation and insulin resistance. Sirt family proteins are reported to de-acetylate Nf-kB molecules and have important roles in initial response against endotoxin and the following endotoxin tolerance.

This Special Issue is open to researchers throughout the world who are interested in epigenetic fields of immunity, including basic and clinical research, innovative applications, and therapeutic challenges. Contributions in terms of advanced reviews, methodological developments, or innovative applications of epigenetics in immunology are all welcome. We aim to publish high-quality research papers that employ a variety of rigorous methods, strong empirical evidence, and extensive numerical results.

Potential topics include but are not limited to the following:

  • Methylation or de-methylation of DNA or RNA, which can regulate the transcriptional ability of a promoter or coding sequence
  • Protein post-translational modifications (including acetylation, methylation, phosphorylation, ubiquitination, sumoylation, ribosylation, and citrullination), which can alter protein function at a translational level without sequence change
  • Noncoding RNAs, which are from transcribed DNA but not translated into protein, that function as a regulator at transcriptional and post-transcriptional levels
Journal of Immunology Research
 Journal metrics
See full report
Acceptance rate27%
Submission to final decision63 days
Acceptance to publication24 days
Journal Citation Indicator0.580
Impact Factor4.493

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.